tradingkey.logo

Becton Dickinson and Co

BDX

177.945USD

+2.445+1.39%
시장 운영 시간 ET시세는 15분 지연됩니다
51.00B시가총액
34.05P/E TTM

Becton Dickinson and Co

177.945

+2.445+1.39%
자세한 내용은 Becton Dickinson and Co 회사
Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, and more. Its BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. The BD Medical segment consists of various business units, including medication delivery solutions, medication management solutions, advanced monitoring, and pharmaceutical systems. Its BD Life Sciences segment provides products for the collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. Its BD Interventional segment provides vascular, urology, oncology and surgical specialty products.
회사 정보
종목 코드 BDX
회사 이름Becton Dickinson and Co
상장일Sep 25, 1963
설립일1906
CEOMr. Thomas E. Polen
직원 수74000
유형Ordinary Share
회계 연도 종료Sep 25
주소One Becton Drive
도시FRANKLIN LAKES
증권 거래소NYSE Consolidated
국가United States of America
우편 번호07417-1880
전화12018476800
웹사이트https://www.bd.com/
종목 코드 BDX
상장일Sep 25, 1963
설립일1906
회사 임원
이름
이름/직위
직위
주식 보유
변동
Mr. Richard (Rick) Byrd
Mr. Richard (Rick) Byrd
Executive Vice President, President - Interventional Segment
Executive Vice President, President - Interventional Segment
754.64K
-0.32%
Mr. Timothy M. (Tim) Ring
Mr. Timothy M. (Tim) Ring
Independent Director
Independent Director
59.87K
+1.58%
Ms. Shana Carol Neal
Ms. Shana Carol Neal
Chief People Officer, Executive Vice President
Chief People Officer, Executive Vice President
47.02K
-3.86%
Ms. Catherine M. (Cathy) Burzik
Ms. Catherine M. (Cathy) Burzik
Independent Director
Independent Director
14.81K
+6.70%
Mr. Roland Goette
Mr. Roland Goette
Executive Vice President, President - EMEA
Executive Vice President, President - EMEA
14.21K
-8.25%
Mr. Antoine C. Ezell
Mr. Antoine C. Ezell
Executive Vice President, President, North America, Chief Marketing Officer
Executive Vice President, President, North America, Chief Marketing Officer
11.97K
+28.43%
Mr. Michael Feld
Mr. Michael Feld
Executive Vice President, President - Life Sciences
Executive Vice President, President - Life Sciences
9.19K
+38.45%
Mr. Robert Andrew (Andy) Eckert
Mr. Robert Andrew (Andy) Eckert
Independent Director
Independent Director
9.14K
+11.33%
Ms. Michelle Quinn
Ms. Michelle Quinn
Executive Vice President, General Counsel
Executive Vice President, General Counsel
6.93K
+39.80%
Dr. Carrie L. Byington, M.D.
Dr. Carrie L. Byington, M.D.
Independent Director
Independent Director
5.25K
+21.54%
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. Richard (Rick) Byrd
Mr. Richard (Rick) Byrd
Executive Vice President, President - Interventional Segment
Executive Vice President, President - Interventional Segment
754.64K
-0.32%
Mr. Timothy M. (Tim) Ring
Mr. Timothy M. (Tim) Ring
Independent Director
Independent Director
59.87K
+1.58%
Ms. Shana Carol Neal
Ms. Shana Carol Neal
Chief People Officer, Executive Vice President
Chief People Officer, Executive Vice President
47.02K
-3.86%
Ms. Catherine M. (Cathy) Burzik
Ms. Catherine M. (Cathy) Burzik
Independent Director
Independent Director
14.81K
+6.70%
Mr. Roland Goette
Mr. Roland Goette
Executive Vice President, President - EMEA
Executive Vice President, President - EMEA
14.21K
-8.25%
Mr. Antoine C. Ezell
Mr. Antoine C. Ezell
Executive Vice President, President, North America, Chief Marketing Officer
Executive Vice President, President, North America, Chief Marketing Officer
11.97K
+28.43%
수익 분석
통화: USD마지막 업데이트: Sun, Jul 6
통화: USD마지막 업데이트: Sun, Jul 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2021
FY2020
FY2019
사업별USD
이름
수익
비율
Medication Delivery Solutions
1.12B
21.19%
Medication Management Solutions
811.00M
15.38%
Pharmaceutical Systems
575.00M
10.91%
Peripheral Intervention
481.00M
9.12%
Integrated Diagnostic Solutions
456.00M
8.65%
Other
1.83B
34.75%
지역별USD
이름
수익
비율
United States
3.11B
58.93%
International
2.16B
41.05%
사업별
지역별
사업별USD
이름
수익
비율
Medication Delivery Solutions
1.12B
21.19%
Medication Management Solutions
811.00M
15.38%
Pharmaceutical Systems
575.00M
10.91%
Peripheral Intervention
481.00M
9.12%
Integrated Diagnostic Solutions
456.00M
8.65%
Other
1.83B
34.75%
주식 보유 통계
마지막 업데이트: Thu, May 15
마지막 업데이트: Thu, May 15
주주
주주 유형
주주
주주
비율
The Vanguard Group, Inc.
11.27%
BlackRock Institutional Trust Company, N.A.
5.16%
State Street Global Advisors (US)
4.88%
T. Rowe Price Investment Management, Inc.
4.39%
T. Rowe Price Associates, Inc.
3.80%
Other
70.50%
주주
주주
비율
The Vanguard Group, Inc.
11.27%
BlackRock Institutional Trust Company, N.A.
5.16%
State Street Global Advisors (US)
4.88%
T. Rowe Price Investment Management, Inc.
4.39%
T. Rowe Price Associates, Inc.
3.80%
Other
70.50%
주주 유형
주주
비율
Investment Advisor
41.25%
Investment Advisor/Hedge Fund
40.93%
Hedge Fund
3.21%
Research Firm
2.94%
Pension Fund
2.75%
Bank and Trust
1.65%
Sovereign Wealth Fund
1.23%
Individual Investor
0.57%
Insurance Company
0.30%
Other
5.17%
기관 주식 보유
마지막 업데이트: Tue, Jul 1
마지막 업데이트: Tue, Jul 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q2
2825
272.14M
94.95%
-10.12M
2025Q1
2897
269.10M
93.89%
-12.90M
2024Q4
2874
271.53M
94.56%
-4.62M
2024Q3
2787
266.29M
92.14%
-3.20M
2024Q2
2782
261.01M
90.31%
-2.68M
2024Q1
2797
255.99M
88.58%
-10.13M
2023Q4
2783
259.38M
89.78%
-7.79M
2023Q3
2768
264.64M
91.23%
-591.87K
2023Q2
2787
263.29M
90.78%
-570.64K
2023Q1
2795
257.22M
90.56%
-8.75M
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
The Vanguard Group, Inc.
32.31M
11.27%
+4.44M
+15.92%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
14.79M
5.16%
-22.91K
-0.15%
Mar 31, 2025
State Street Global Advisors (US)
13.99M
4.88%
-94.83K
-0.67%
Mar 31, 2025
T. Rowe Price Investment Management, Inc.
12.58M
4.39%
+448.64K
+3.70%
Mar 31, 2025
T. Rowe Price Associates, Inc.
10.89M
3.8%
-1.04M
-8.70%
Mar 31, 2025
Geode Capital Management, L.L.C.
6.48M
2.26%
+127.97K
+2.01%
Mar 31, 2025
MFS Investment Management
6.11M
2.13%
+655.88K
+12.02%
Mar 31, 2025
First Eagle Investment Management, L.L.C.
5.52M
1.93%
+1.09M
+24.64%
Mar 31, 2025
Generation Investment Management LLP
5.30M
1.85%
-518.93K
-8.92%
Mar 31, 2025
Morgan Stanley Investment Management Ltd. (UK)
4.96M
1.73%
-737.71K
-12.95%
Mar 31, 2025
더 보기
관련 ETF
마지막 업데이트: Sun, Jul 6
마지막 업데이트: Sun, Jul 6
이름
비율
iShares U.S. Medical Devices ETF
4.36%
American Century Focused Large Cap Value ETF
3.16%
First Eagle Global Equity ETF
3.14%
T Rowe Price Capital Appreciation Equity ETF
3.11%
Franklin ClearBridge Enhanced Income ETF
2.93%
iShares Large Cap Value Active ETF
2.34%
Running Oak Efficient Growth ETF
1.9%
SPDR S&P Health Care Equipment ETF
1.8%
T Rowe Price Equity Income ETF
1.72%
First Trust Indxx Medical Devices ETF
1.61%
더 보기
iShares U.S. Medical Devices ETF
비율4.36%
American Century Focused Large Cap Value ETF
비율3.16%
First Eagle Global Equity ETF
비율3.14%
T Rowe Price Capital Appreciation Equity ETF
비율3.11%
Franklin ClearBridge Enhanced Income ETF
비율2.93%
iShares Large Cap Value Active ETF
비율2.34%
Running Oak Efficient Growth ETF
비율1.9%
SPDR S&P Health Care Equipment ETF
비율1.8%
T Rowe Price Equity Income ETF
비율1.72%
First Trust Indxx Medical Devices ETF
비율1.61%
주식 배당금
지난 5년 동안 총 5.34B USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
Jan 28, 2025
BDX.NB Interim Cash Dividend of gross USD 1.04 paid on Mar 31, 2025 going ex on Mar 10, 2025
Mar 10, 2025
Mar 31, 2025
Mar 10, 2025
Nov 07, 2024
BDX.NB Final Cash Dividend of gross USD 1.04 paid on Dec 31, 2024 going ex on Dec 09, 2024
Dec 09, 2024
Dec 31, 2024
Dec 09, 2024
Jul 23, 2024
BDX.NB Interim Cash Dividend of gross USD 0.95 paid on Sep 30, 2024 going ex on Sep 09, 2024
Sep 09, 2024
Sep 30, 2024
Sep 09, 2024
Apr 30, 2024
BDX.NB Interim Cash Dividend of gross USD 0.95 paid on Jun 28, 2024 going ex on Jun 10, 2024
Jun 10, 2024
Jun 28, 2024
Jun 10, 2024
Jan 23, 2024
BDX.NB Interim Cash Dividend of gross USD 0.95 paid on Mar 29, 2024 going ex on Mar 07, 2024
Mar 08, 2024
Mar 29, 2024
Mar 07, 2024
Nov 09, 2023
BDX.NB Final Cash Dividend of gross USD 0.95 paid on Dec 29, 2023 going ex on Dec 07, 2023
Dec 08, 2023
Dec 29, 2023
Dec 07, 2023
Jul 25, 2023
BDX.NB Interim Cash Dividend of gross USD 0.91 paid on Sep 29, 2023 going ex on Sep 07, 2023
Sep 08, 2023
Sep 29, 2023
Sep 07, 2023
Apr 25, 2023
BDX.NB Interim Cash Dividend of gross USD 0.91 paid on Jun 30, 2023 going ex on Jun 08, 2023
Jun 09, 2023
Jun 30, 2023
Jun 08, 2023
Jan 24, 2023
BDX.NB Interim Cash Dividend of gross USD 0.91 paid on Mar 31, 2023 going ex on Mar 09, 2023
Mar 10, 2023
Mar 31, 2023
Mar 09, 2023
Nov 10, 2022
BDX.NB Final Cash Dividend of gross USD 0.91 paid on Dec 30, 2022 going ex on Dec 08, 2022
Dec 09, 2022
Dec 30, 2022
Dec 08, 2022
더 보기
주식 분할
날짜
유형
비율
데이터 없음
날짜
유형
비율
데이터 없음
tradingkey.logo
tradingkey.logo
당일 거래 데이터는 Refinitiv에서 제공하며, 이용 약관이 적용됩니다. 역사적 및 현재 종가 데이터는 Refinitiv에서 제공합니다. 모든 시세는 현지 거래소 시간 기준입니다. 미국 주식 시세의 실시간 마지막 거래 데이터는 Nasdaq을 통해 보고된 거래만 반영됩니다. 당일 거래 데이터는 최소 15분 지연되거나 거래소 요구 사항에 따라 다를 수 있습니다.
* 참고자료, 분석 및 트레이딩 전략은 제3자 제공업체인 Trading Central에서 제공하며, 분석가의 독립적인 평가와 판단에 기반한 시각으로, 투자자의 투자 목표와 재정 상황은 고려되지 않습니다.
위험 경고: 저희 웹사이트와 모바일 앱은 특정 투자 상품에 대한 일반적인 정보만을 제공합니다. Finsights는 재정적 조언이나 투자 상품에 대한 추천을 제공하지 않으며, 이러한 정보 제공이 Finsights가 금융 조언이나 추천을 제공하는 것으로 해석되어서는 안 됩니다.
투자 상품은 투자 원금 손실을 포함한 상당한 투자 위험에 노출되어 있으며, 모든 사람에게 적합하지 않을 수 있습니다. 투자 상품의 과거 성과는 미래 성과를 보장하지 않습니다.
Finsights는 제3자 광고주나 제휴사가 저희 웹사이트나 모바일 앱 또는 그 일부에 광고를 게재하거나 전달할 수 있도록 허용할 수 있으며, 사용자가 광고와 상호작용하는 방식에 따라 이들로부터 보상을 받을 수 있습니다.
© 저작권: FINSIGHTS MEDIA PTE. LTD. 모든 권리 보유
KeyAI